 Editas Medicine, Inc. NASDAQ:EDIT Q3 2022 Earnings Conference Call November 2, 2022 8:00 AM ET Company Participants Ron Moldaver - Investor Relations Gilmore ONeill - Chief Executive Officer Baisong Mei - Chief Medical Officer Mark Shearman - Chief Scientific Officer Michelle Robertson - Chief Financial Officer Conference Call Participants Gena Wang - Barclays Greg Harrison - Bank of America Joon Lee - Truist Securities Dae Gon Ha - Stifel Phil Nadeau - Cowen Co. Jay Olson - Oppenheimer Joel Beatty - Baird Yanan Zhu - Wells Fargo Securities Liisa Bayko - Evercore ISI Operator Good morning and welcome to Editas Medicines Third Quarter 2022 Conference Call. All participants are now in a listen-only mode. 